Loading...

Home
ETF
DTIL

DTIL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press
Privacy
Terms of Service
Service Terms of Use

Resources

Blog
Tutorial
Help Center
Affiliate Program

Markets

Market Analysis
Crypto
Featured Screeners
AI Earnings Calendar
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

QuantAI Alpha Pick
SwingMax Portfolio
Swing Trading
AI Stock Picker
Whales Auto Tracker
Daytrading Center
Patterns Detection
AI Screener
Financial AI Agent
Backtesting Playground
AI Earnings Prediction
Stock Monitor
Technical Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

DTIL News

PBGENE-DMD Treatment Shows Durable Efficacy

18h agoYahoo Finance

Precision BioSciences' PBGENE-DMD Receives FDA Fast Track Designation

1d agoNASDAQ.COM

Precision BioSciences Receives FDA Fast Track Designation for PBGENE-DMD

1d agoNewsfilter

FDA Grants Fast Track Designation to PBGENE-DMD for DMD Treatment

1d agoYahoo Finance

FDA Approval Enables Initiation of DMD Clinical Trial

Feb 11 2026Newsfilter

Precision BioSciences Receives FDA Approval for Clinical Trial

Feb 11 2026Yahoo Finance

Precision BioSciences Advances PBGENE-HBV and PBGENE-DMD Trials, Data Updates Expected in 2026

Jan 12 2026Yahoo Finance

iECURE Secures FDA RMAT Designation for ECUR-506, Advancing OTC Deficiency Treatment

Jan 07 2026Newsfilter

Biotech Stocks Surge in After-Hours Trading with Gains from BioAtla, Entero, and Sonnet

Dec 01 2025NASDAQ.COM

Precision BioSciences Initiates $75 Million Stock and Warrant Sale

Nov 11 2025SeekingAlpha

Precision BioSciences Unveils $75 Million Common Stock, Pre-Funded Warrants, and Warrant Offering

Nov 10 2025Yahoo Finance

Precision BioSciences Unveils New Phase 1 PBGENE-HBV Findings at AASLD The Liver Meeting®, Highlighting Safety, Tolerability, and Dose-Dependent Antiviral Effects in Initial Three Cohorts

Nov 10 2025Newsfilter

Precision BioSciences Publishes Study in Nucleic Acids Research on High-Efficiency Gene Insertion Mechanisms in Dividing and Non-Dividing Cells with ARCUS Nucleases

Oct 09 2025Newsfilter

Precision BioSciences Unveils First U.S. Clinical Trial Site for ELIMINATE-B Study

Oct 07 2025Newsfilter

DFAS's Assets May Indicate a 15% Profit Opportunity

Oct 02 2025NASDAQ.COM

Precision BioSciences to Present Late-Breaking Poster at the 30th Annual World Muscle Society Congress

Sep 30 2025Newsfilter